Ileal adenocarcinoma in a mild phenotype of abetalipoproteinemia

被引:23
作者
Al-Shali, K
Wang, J
Rosen, F
Hegele, RA
机构
[1] John P Robarts Res Inst, Blackburn Cardiovasc Genet Lab, London, ON N6A 5K8, Canada
[2] Univ Western Ontario, Div Endocrinol, London, ON N6A 3K7, Canada
[3] Scarborough Gen Hosp, Gen Div, Div Endocrinol, Toronto, ON, Canada
关键词
abetalipoproteinemia; acanthocytes; apolipoprotein B; intestinal neoplasia; retinitis pigmentosa;
D O I
10.1046/j.0009-9163.2002.00175.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Abetalipoproteinemia (ABL) is a rare autosomal recessive disorder that is characterized by defective assembly and secretion of plasma apolipoprotein (apo) B-containing lipoproteins. This disorder results from mutations in the MTP gene encoding the microsomal triglyceride transfer protein. We report a 58-year-old male homozygote for a missense mutation, S590I, in MTP. The patient had a lifelong history of fat malabsorption, but was only diagnosed with ABL at age 52, based upon such classic features as absence of apo B-containing lipoproteins, acanthocytosis, atypical retinitis pigmentosa and markedly depressed serum beta-carotene concentration. However, his presentation was notable not only by survival to the sixth decade of life without specific treatment, but also by the absence of neurological involvement and by normal serum vitamin E concentration. He subsequently developed adenocarcinoma of the ileum, which required ileal resection. Therefore, this missense mutation appears to be associated with a late-presenting and relatively mild ABL phenotype that lacks some classical features, particularly neuropathy, but appears to be associated with other atypical features, specifically small intestinal cancer.
引用
收藏
页码:135 / 138
页数:4
相关论文
共 25 条
  • [11] KAYDEN HJ, 1980, NUTR REV, V38, P244
  • [12] LEIPER JM, 1994, J BIOL CHEM, V269, P21951
  • [13] NARCISI TME, 1995, AM J HUM GENET, V57, P1298
  • [14] Ohashi K, 2000, J LIPID RES, V41, P1199
  • [15] A 30-AMINO ACID TRUNCATION OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN LARGE SUBUNIT DISRUPTS ITS INTERACTION WITH PROTEIN DISULFIDE-ISOMERASE AND CAUSES ABETALIPOPROTEINEMIA
    RICCI, B
    SHARP, D
    OROURKE, E
    KIENZLE, B
    BLINDERMAN, L
    GORDON, D
    SMITHMONROY, C
    ROBINSON, G
    GREGG, RE
    RADER, DJ
    WETTERAU, JR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) : 14281 - 14285
  • [16] A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors
    Robl, JA
    Sulsky, R
    Sun, CQ
    Simpkins, LM
    Wang, T
    Dickson, JK
    Chen, Y
    Magnin, DR
    Taunk, P
    Slusarchyk, WA
    Biller, SA
    Lan, SJ
    Connolly, F
    Kunselman, LK
    Sabrah, T
    Jamil, D
    Gordon, D
    Harrity, TW
    Wetterau, JR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (06) : 851 - 856
  • [17] CLONING AND GENE DEFECTS IN MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN ASSOCIATED WITH ABETALIPOPROTEINEMIA
    SHARP, D
    BLINDERMAN, L
    COMBS, KA
    KIENZLE, B
    RICCI, B
    WAGERSMITH, K
    GIL, CM
    TURCK, CW
    BOUMA, ME
    RADER, DJ
    AGGERBECK, LP
    GREGG, RE
    GORDON, DA
    WETTERAU, JR
    [J]. NATURE, 1993, 365 (6441) : 65 - 69
  • [18] MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion
    Shiomi, M
    Ito, T
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 431 (01) : 127 - 131
  • [19] ABETALIPOPROTEINEMIA IS CAUSED BY DEFECTS OF THE GENE ENCODING THE 97 KDA SUBUNIT OF A MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN
    SHOULDERS, CC
    BRETT, DJ
    BAYLISS, JD
    NARCISI, TME
    JARMUZ, A
    GRANTHAM, TT
    LEONI, PRD
    BHATTACHARYA, S
    PEASE, RJ
    CULLEN, PM
    LEVI, S
    BYFIELD, PGH
    PURKISS, P
    SCOTT, J
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (12) : 2109 - 2116
  • [20] SPERLING MA, 1971, PEDIATRICS, V48, P91